Cargando…

Medical assistance in living after failure of ECT and ketamine

Detalles Bibliográficos
Autores principales:	Lafrenière, Simon, Blier, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2022
Materias:	Psychopharmacology for the Clinician
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467462/ http://dx.doi.org/10.1503/jpn.220068

Ejemplares similares

Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination
por: Thompson, Deborah, et al.
Publicado: (2021)

Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems
por: Gazzellone, Matthew J., et al.
Publicado: (2022)

Use of repetitive transcranial magnetic stimulation in the treatment of catatonia
por: Licht, Christiane, et al.
Publicado: (2022)

Clinical management of psychosis in 22q11.2 deletion syndrome
por: Iftimovici, Anton, et al.
Publicado: (2022)

Binge eating disorder hidden behind a wall of anxiety disorders
por: Pipe, Amy, et al.
Publicado: (2021)

The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
por: Garel, Nicolas, et al.
Publicado: (2021)

Use of MAOIs in severe treatment-resistant depression: back to the old school
por: Cookey, Jacob
Publicado: (2021)

Oculogyric crisis: a rare type of dystonia
por: Boi, Sara, et al.
Publicado: (2021)

Serotonin syndrome: SSRIs are not the only culprit
por: Garel, Nicolas, et al.
Publicado: (2021)

To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians
por: Muntingh, Anna, et al.
Publicado: (2021)

Population pharmacokinetics and dosing of long-acting injectable antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Prescribing differently for women with first-episode psychosis
por: Sabesan, Priyadharshini, et al.
Publicado: (2021)

Utilizing pharmacogenetics when treating first episode psychosis
por: Korchia, Theo, et al.
Publicado: (2023)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptoms
por: Garel, Nicolas, et al.
Publicado: (2023)

Favourable cognitive changes observed with metabolic improvements in a patient with severe mental illness
por: van Reekum, Emma A, et al.
Publicado: (2023)

Testogel Application in the Menopause: Making a Difference to the Lives of Women
por: Heald, Adrian, et al.
Publicado: (2023)

'Just Say No' (Or at Least Ask Why) STOMP Medication Reviews in Tower Hamlets Community Learning Disability Service
por: Jones, Anthony, et al.
Publicado: (2022)

The links between the amount of antipsychotic medication prescribed at GP practice level, local demographic factors and medication selection
por: Heald, Adrian, et al.
Publicado: (2021)

The Impact of Prophylactic Medication Use on the Recurrence of Bipolar Episodes in the BDRN Pregnancy Study
por: Dias, Marisa Casanova, et al.
Publicado: (2023)

Assessment of Legibility and Completeness of Prescriptions at Tertiary Care Hospitals: A Cross-Sectional Study
por: Saeed, Sajeel, et al.
Publicado: (2022)

What Is the Evidence for Using Anti-Epileptic Drugs to Treat Agitation and Irritability in Huntington's Disease?
por: Leong, Kok Keong, et al.
Publicado: (2022)

Improving quantification of anticholinergic burden using the Anticholinergic Effect on Cognition Scale – a healthcare improvement study in a geriatric ward setting
por: Balasundaram, Bharathi, et al.
Publicado: (2022)

Adjunct pharmacotherapy for psychotherapy
por: Lochtenberg, Jessica, et al.
Publicado: (2021)

Peripheral cortisol administration blunts reward arousal but heightens anxiety-like arousal in marmosets
por: Alexander, Laith, et al.
Publicado: (2021)

Psilocybin: the magic medicine for depression?
por: Corrigan, Amber Elyse, et al.
Publicado: (2021)

Different onset patterns of monthly paliperidone palmitate in hospitalised patient diagnosed with schizophrenia
por: Herrera-Sánchez, Javier, et al.
Publicado: (2021)

Comparison between the efficiency of pharmacotherapy and cognitive behavioral therapy in reducing captagon (fenethylline) dependence and relapse prevention
por: Binnwejim, Mohammed, et al.
Publicado: (2021)

A narrative review of the pharmacological management of psychosis in Alzheimer's disease
por: Matthews, Alexander, et al.
Publicado: (2021)

Multicentre evaluation of the pharmacological management of women with bipolar disorder in the perinatal period
por: Dias, Marisa Casanova, et al.
Publicado: (2021)

Buspirone in obsessive-compulsive disorder: a potential dark horse?
por: Garg, Kabir, et al.
Publicado: (2021)

Potential drug targets in the kynurenine pathway to treat acute schizophrenia
por: Malhotra, Ayush, et al.
Publicado: (2021)

Challenges of Chemsex in Health, Justice, and Social Care Settings: Developing a Coordinated Response
por: Hillier, Bradley, et al.
Publicado: (2023)

The Effects of Rivastigmine on Neuropsychiatric Symptoms in the Early Stages of Parkinson's Disease: A Systematic Review
por: Reilly, Siobhan, et al.
Publicado: (2023)

Rapid Clozapine Blood Level Determination in a National Health Service Trust
por: Taylor, David, et al.
Publicado: (2023)

Multimorbidity and Polypharmacy in Psychosis: Identifying Potentially Significant Drug Interactions in an Old Age Inpatient Psychiatry Setting
por: Tewari, Abhinav, et al.
Publicado: (2023)

Developing a New Lithium Policy
por: Wong, Brandon, et al.
Publicado: (2023)

The Geriatric Population and Psychiatric Medication
por: Varma, Sannidhya, et al.
Publicado: (2010)

Concepts for selection and utilization of psychiatric medications in pregnancy
por: Vickery, P. Brittany
Publicado: (2023)

Medication management of bipolar disorder during the reproductive years
por: Kennedy, Mary Lindsey Hedgepeth
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7l56lnknidjn08l05vtifichfb